GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Net Income (Continuing Operations)

Indo-Bangla Pharmaceuticals (DHA:IBP) Net Income (Continuing Operations) : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Indo-Bangla Pharmaceuticals's Net Income (Continuing Operations) for the six months ended in . 20 was BDT0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Net Income (Continuing Operations) Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Net Income (Continuing Operations) Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Net Income (Continuing Operations)

Indo-Bangla Pharmaceuticals Semi-Annual Data
Net Income (Continuing Operations)

Indo-Bangla Pharmaceuticals Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals  (DHA:IBP) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Indo-Bangla Pharmaceuticals Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Net Income (Continuing Operations)
Comparable Companies
Traded in Other Exchanges
N/A
Address
Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Website
http://www.indo-banglapharma.com
Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.